Core Viewpoint - The financial report of Haineng Future (stock code: 920476) for the third quarter of 2025 indicates significant changes in both revenue and net profit, showcasing a strong recovery compared to the previous year [2][3]. Financial Data Summary Major Financial Data - Total assets decreased by 5.11% from 560.18 billion to 531.56 billion [3]. - Net assets attributable to shareholders decreased by 8.78% from 471.78 billion to 430.37 billion [3]. - The asset-liability ratio (parent company) increased from 3.63% to 11.15% [3]. - The consolidated asset-liability ratio rose from 15.83% to 19.91% [3]. Revenue and Profit Analysis - Operating revenue for the first nine months of 2025 was 227.24 billion, up 23.54% from 183.94 billion in the same period of 2024 [3]. - Net profit attributable to shareholders surged by 487.07%, reaching 18.11 billion compared to a loss of 4.68 million in the previous year [3]. - Basic earnings per share increased by 466.67%, from -0.06 to 0.22 yuan [3]. Quarterly Performance - For the third quarter of 2025, operating revenue was 91.17 billion, a 9.78% increase from 83.05 billion in Q3 2024 [3]. - Net profit attributable to shareholders rose by 35.28%, from 9.34 million to 12.63 million [3]. - Basic earnings per share for Q3 increased by 45.45%, from 0.11 to 0.16 yuan [3]. Significant Changes in Financial Data Major Changes in Assets and Liabilities - Prepayments increased by 95.39% due to prepayment for information system usage fees and increased inventory [4]. - Other current assets rose by 70.32% due to increased prepaid taxes [4]. - Construction in progress decreased by 100% as the production line renovation project was completed [4]. - Long-term prepaid expenses increased by 34.26% due to the completion of renovation projects [4]. Changes in Cash Flow - Net cash flow from operating activities improved significantly, with a 99.02% increase in cash flow, reflecting higher cash receipts from sales [5]. - Net cash flow from investment activities showed a drastic decline of 380.19% due to investments in the construction of the Haineng Future Science Instrument Intelligent Manufacturing Base [5]. - Cash flow from financing activities decreased by 63.74% primarily due to stock repurchase activities [5]. Shareholder Structure - The total number of ordinary shares at the end of the reporting period was 85.18 million, with 94.57% being unrestricted shares [6]. - The largest shareholder, Wang Zhigang, holds 19.08% of the shares [8]. - The top ten shareholders collectively hold 39.83% of the shares, with no inter-relationships among them [8]. Major Events and Compliance - The company has been involved in litigation and arbitration matters, with no significant unresolved cases reported [11][13]. - The company has complied with internal review procedures for significant transactions and has fulfilled disclosure obligations in a timely manner [11].

Investment Rating - The investment rating for the company is "Buy" (maintained) [5] Core Views - The company has shown continuous high performance in its earnings, with the recent launch of a new near-infrared spectrometer expected to drive additional revenue growth [5] - The company reported a revenue of 227 million yuan for Q1-Q3 2025, representing a year-on-year increase of 24%, and a net profit attributable to shareholders of 18.11 million yuan, marking a turnaround from losses [7] - The company is focusing on expanding its international distribution channels and participating in significant exhibitions to accelerate overseas growth [7] Financial Performance Summary - Revenue projections for the company are as follows: 341 million yuan in 2023, 310 million yuan in 2024, 370 million yuan in 2025E, 437 million yuan in 2026E, and 526 million yuan in 2027E [6] - The company achieved a net profit of 12.63 million yuan in Q3 2025, which is a 35% increase year-on-year and a 111% increase quarter-on-quarter [7] - The company’s R&D expenses for Q1-Q3 2025 were 38.71 million yuan, with a R&D expense ratio of 17%, indicating a strong focus on high-end instrument localization [7] Earnings Forecast and Valuation - The forecasted net profits for the company from 2025 to 2027 are 50 million yuan, 63 million yuan, and 80 million yuan, respectively, corresponding to price-to-earnings ratios of 46.0, 36.5, and 28.8 times [8] - The company has been actively repurchasing shares, completing a buyback plan in October 2025, which accounted for 4.1% of the total share capital [7]

Investment Rating - The report maintains a "Buy" rating for the company, indicating a positive outlook on its stock performance relative to the market [3][5]. Core Insights - The company has demonstrated strong revenue growth, with a year-over-year increase of 23.5% in the first three quarters of 2025, reaching a revenue of 230 million yuan. The net profit attributable to shareholders surged by 487.1% to 20 million yuan during the same period [1]. - The company has successfully reduced its overall expense ratio, with significant decreases in sales, management, financial, and R&D expense ratios, contributing to improved cash flow and operational efficiency [2]. - The completion of the share buyback program, with a total of 5.089 million shares repurchased, reflects the company's confidence in its future growth prospects [3]. Financial Performance - For the first three quarters of 2025, the company achieved a gross margin of 63.4%, consistent with the previous year. The net cash flow from operating activities improved significantly, increasing by 99% year-over-year [2]. - The company is focusing on the liquid chromatography product line and has established a research partnership with Xi'an Jiaotong University to enhance its capabilities in scientific instrumentation [2]. - The financial projections for 2025 to 2027 estimate revenues of 370 million, 450 million, and 540 million yuan, respectively, with net profits expected to reach 50 million, 70 million, and 90 million yuan [3][4]. Market Position and Strategy - The company is strategically expanding into high-tech areas, particularly in chromatography, with products like the "Wukong" high-efficiency liquid chromatography instrument and the "GAS" gas chromatography-ion mobility spectrometry combined instrument, which are expected to drive future growth [2]. - The adjustment of the share buyback price cap from 15 yuan to 25 yuan per share indicates a strong belief in the company's valuation and future performance [3].

证券代码：920476 证券简称：海能技术 公告编号：2025-132 海能未来技术集团股份有限公司 第五届董事会第十次临时会议决议公告 3.会议召开方式：现场结合通讯方式 4.发出董事会会议通知的时间和方式：2025 年 10 月 22 日以电子邮件方式发 出 5.会议主持人：董事长张振方先生 6.会议列席人员：高级管理人员 7.召开情况合法合规的说明： 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 一、会议召开和出席情况 （一）会议召开情况 1.会议召开时间：2025 年 10 月 27 日 2.会议召开地点：山东省德州市临邑县花园东大街 16 号公司会议室 2.议案表决结果：同意 7 票；反对 0 票；弃权 0 票。 本议案已经公司董事会审计委员会 2025 年第三次会议审议通过。 3.回避表决情况： 本次会议的召集、召开、议案审议程序等符合有关法律、行政法规、部门规 章、规范性文件和《公司章程》的规定。 （二）会议出席情况 会议应出席董事 7 人，出席和授权出席董事 7 人。 董事徐渊、刘文玉 ...

Group 1 - The report highlights the emphasis on building a strong aerospace nation as proposed in the recent Central Committee meeting, with a focus on scarce aerospace targets listed on the Beijing Stock Exchange [1][12][17] - As of October 24, 2025, there are 20 companies in the aerospace and military sectors on the Beijing Stock Exchange, with a total market capitalization of 76.032 billion yuan [1][17] - Key companies to watch include Xingtum Control (920116.BJ), Fujida (835640.BJ), and Chuangyuan Xinke, which have shown significant growth and technological advancements in their respective fields [1][22][24] Group 2 - The five major industries on the Beijing Stock Exchange reported average weekly gains, with high-end equipment, information technology, chemical new materials, consumer services, and pharmaceutical biology showing increases of +4.29%, +4.36%, +3.85%, +2.43%, and +3.28% respectively [2][29] - The median P/E ratios for these industries have also risen, with high-end equipment at 41.9X, information technology at 71.0X, and chemical new materials at 41.5X [2][30][36] Group 3 - In the technology new industries, 143 out of 156 companies saw an increase, with a median growth of +4.42% during the reporting period [3][45] - The median P/E ratio for technology new industries increased from 45.8X to 46.9X, and total market capitalization rose from 471.131 billion yuan to 492.000 billion yuan [3][46][47] Group 4 - The report emphasizes the acceleration of quarterly report disclosures, highlighting companies with high growth and scarce quality targets [4][67] - Notable companies include Guangxin Technology, which reported a 41.35% increase in total revenue and a 91.95% increase in net profit for the first three quarters of 2025 [4][68] - Other companies like Changhong Energy and Kexin New Materials also reported significant revenue and profit growth during the same period [4][69]

证券代码：920476 证券简称：海能技术 公告编号：2025-131 海能未来技术集团股份有限公司 (一)审议及表决情况 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、误导 性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带法律责任。 海能未来技术集团股份有限公司（以下简称"公司"）于 2025 年 3 月 20 日召开了 第五届董事会第五次临时会议、第五届监事会第三次临时会议，审议通过了《关于以集 中竞价交易方式回购公司股份方案的议案》。 一、 回购方案基本情况 (二)回购用途及目的 基于对公司未来发展的信心及公司价值的认可，为维护广大投资者的利益，增强投 资者信心，推进股票价值与公司内在价值相匹配，提升公司股票长期投资价值，公司积 极响应党中央、国务院决策部署，根据中国人民银行、金融监管总局、中国证监会《关 于设立股票回购增持再贷款有关事宜的通知》，公司决定以自有资金及银行提供的股票 回购专项贷款资金回购公司股份。 本次回购的股份将用于实施股权激励，以引进和稳定优秀经营管理人才，提升经营 管理团队的凝聚力，推进长期激励与约束机制，使各方共同关注公司的长远发展，确保 ...

上市公司：创远信科（831961），奥迪威（832491），同惠电子（833509），海能技术（430476），新 芝生物（430685），基康仪器（830879），天罡股份（832651），驰诚股份（834407），莱赛激光 （871263） 数据来源：国家统计局，智研咨询整理 相关报告：智研咨询发布的《2026-2032年中国仪器仪表市场供需预测及未来发展趋势报告》 2025年1-8月，仪器仪表制造业企业数（以下数据涉及的企业，均为规模以上工业企业，从2011年起， 规模以上工业企业起点标准由原来的年主营业务收入500万元提高到年主营业务收入2000万元）为7653 个，和上年同期相比，增加了433个，同比增长6%，占工业总企业的比重为1.47%。 2016-2025年1-8月仪器仪表制造业企业数统计图 知前沿，问智研。智研咨询是中国一流产业咨询机构，十数年持续深耕产业研究领域，提供深度产业研 究报告、商业计划书、可行性研究报告及定制服务等一站式产业咨询服务。专业的角度、品质化的服 务、敏锐的市场洞察力，专注于提供完善的产业解决方案，为您的投资决策赋能。 ...

Core Viewpoint - The manufacturing sector in China has shown growth in the number of enterprises, indicating a positive trend in industrial development and investment opportunities [1] Group 1: Manufacturing Sector Overview - As of January to August 2025, the number of manufacturing enterprises reached 485,538, an increase of 15,857 compared to the same period last year, representing a year-on-year growth of 3.38% [1] - The manufacturing enterprises account for 93.12% of the total industrial enterprises, highlighting the sector's dominance in the industrial landscape [1] Group 2: Industry Reports and Insights - Zhiyan Consulting has released a report titled "Analysis of the Competitive Landscape and Investment Development Research of China's Manufacturing Industry from 2025 to 2031," providing in-depth insights into market trends and investment strategies [1] - The report emphasizes the importance of comprehensive industry solutions to empower investment decisions, showcasing Zhiyan Consulting's expertise in the field [1]

数据来源：国家统计局，智研咨询整理 知前沿，问智研。智研咨询是中国一流产业咨询机构，十数年持续深耕产业研究领域，提供深度产业研 究报告、商业计划书、可行性研究报告及定制服务等一站式产业咨询服务。专业的角度、品质化的服 务、敏锐的市场洞察力，专注于提供完善的产业解决方案，为您的投资决策赋能。 根据国家统计局数据可知：2025年8月全国仪器仪表制造业出口货值为143.8亿元，同比增长0.3%；2025 年1-8月全国仪器仪表制造业累计出口货值为1101.4亿元，累计同比增长9.8%。 2019年-2025年1-8月全国仪器仪表制造业出口货值统计图 上市公司：创远信科（831961），奥迪威（832491），同惠电子（833509），海能技术（430476），新 芝生物（430685），基康仪器（830879），天罡股份（832651），驰诚股份（834407），莱赛激光 （871263） 相关报告：智研咨询发布的《2025-2031年中国仪器仪表市场供需预测及未来发展趋势报告》 ...

Group 1 - The report highlights that the Beijing Stock Exchange (BSE) has fully entered the "920 new code" era, which is expected to further solidify its independent status as China's third-largest stock exchange [3][8] - The transition to the 920 code is seen as a significant milestone in the development of the BSE, addressing the confusion caused by multiple existing code segments and enhancing stock identification [3][8] - The report emphasizes the ongoing implementation of the "Deep Reform 19 Articles" strategy, indicating continuous policy support for the high-quality development of the BSE, with expectations for new products like specialized index funds and ETFs [3][8] Group 2 - The report notes that the BSE's market may experience short-term volatility due to fluctuating tariff policies and overall market conditions, but it encourages a focus on long-term investment opportunities [3][12] - It identifies several key investment themes, including companies with stable long-term performance, those with upcoming quarterly reports, and sectors related to self-sufficiency and domestic consumption [3][12][29] - The report mentions that the overall price-to-earnings (PE) ratio for BSE A-shares remains at 50X, with daily trading volume recovering to 193 billion [14][15] Group 3 - The report states that one new company, Aomeisen, was listed on the BSE during the week, bringing the total number of new listings since January 1, 2024, to 39 [22][23] - It highlights the average issuance PE ratio of 13.95X for the newly listed companies, with an average first-day price fluctuation of 243% [26][29] - The report also notes the registration status of one company and the submission of registration for another, indicating ongoing activity in the IPO pipeline [29][30]